According to The Insight Partners latest study on “Acetaminophen Reagents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, and End User,” the market is projected to reach US$ 750.39 million by 2028 from US$ 539.56 million in 2021; it is expected to grow at a CAGR of 4.8% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
Acetaminophen (paracetamol) is the commonly used analgesic and antipyretic across the world. Acetaminophen reagents are drug testing reagents used to determine the presence of an excessive amount of acetaminophen in a blood sample. The reagents are also used to assess drug levels and are an essential metric in the treatment and dose management of patients suffering from severe renal failure. Factors such as the high incidence of a drugs overdose and the adoption of acetaminophen testing drive the market growth. However, the increased risk of attention deficit hyperactivity disorder (ADHD) and other complications in pregnancy restrict the growth of the market.
Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00026173/
The growth of the acetaminophen reagents market is primarily attributed to factors such as the high incidence of drugs overdose and the adoption of acetaminophen testing. However, the increased risk of attention deficit hyperactivity disorder (ADHD) and other complications in pregnancy hinder the market growth. Biorbyt Ltd.; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Abbott; Sekisui Diagnostics; Beckman Coulter, Inc.; Randox Laboratories, Ltd.; American Screening Corporation, Inc.; EKF Diagnostics; and Bio-Rad Laboratories Inc. are among the leading companies operating in the market.
Based on product, the acetaminophen reagents market is segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pretreatment solution. The antibody/substrate reagent segment held the largest share of the market in 2021. The reagents are offered by various companies in the global acetaminophen reagents market. For instance, Beckman Coulter, Inc. offers antibody/substrate reagent (OSR7A568 R1) in its Emit tox Acetaminophen Assay used for the quantitative analysis of acetaminophen in human serum or plasma. Further, the enzyme reagent segment is expected to register the highest CAGR during 2021–2028.
Based on product, the acetaminophen reagents market is segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pre-treatment solution. Based on application, the market is bifurcated into enzymatic assays and immunoassays. Based on end-users, the acetaminophen reagents market is segmented into hospitals, diagnostics laboratories, POC testing, forensic laboratories, and others.
Inquiry Before Buying at: https://www.theinsightpartners.com/inquiry/TIPRE00026173/
By geography, the global acetaminophen reagents market is segmented into North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. The market in North America is further segmented into the US, Canada, and Mexico. The European acetaminophen reagents market is sub-segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The market in the Asia Pacific is further segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. The market in South and Central America is sub-segmented into Brazil, Argentina, and the Rest of South and Central America. The Middle East and Africa acetaminophen reagents market is further segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East and Africa.
High Incidence of Drugs Overdose Fuels Acetaminophen Reagents Market Growth
Acetaminophen is a commonly used oral antipyretic and analgesic with an excellent safety profile when administered in proper therapeutic doses. It is an over-the-counter (OTC) medicine and is widely available. Acetaminophen can be found in numerous products, due to which people underestimate its toxicity. Various OTC cold and flu medicines contain acetaminophen. The generalized dosage of acetaminophen in adults is up to 3,000 mg of single-ingredient acetaminophen a day and less than 3,000 mg for patients aged 65 years and above. Patients ingest excessive amounts of medicine as they misunderstand dosing directions or cannot recognize the availability of acetaminophen in more than one medication they are using. Consumption of more than decided amounts, especially 7,000 mg or more, can lead to severe overdose problems such as, acute hepatic failure, or become deadly. If a person consumes more than one of OTC medicines containing acetaminophen in the same period, a dangerously high amount of acetaminophen can be found in the blood that can damage the liver. If a patient has any liver or kidney disease history, then the usage of this drug first needs to be discussed with the healthcare provider.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00026173/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi